Loading...
XSTO
STIL
Market cap241mUSD
Jul 10, Last price  
270.50SEK
1D
4.04%
1Q
21.30%
Jan 2017
490.61%
Name

Stille AB

Chart & Performance

D1W1MN
XSTO:STIL chart
P/E
43.64
P/S
4.28
EPS
6.20
Div Yield, %
Shrs. gr., 5y
13.18%
Rev. gr., 5y
31.82%
Revenues
568m
-0.41%
96,611,000100,818,00083,411,00089,909,00088,044,00089,095,00081,467,00083,479,00096,334,000121,818,000135,796,000156,673,000142,627,000187,087,000246,350,000294,893,000569,950,000567,629,000
Net income
56m
-4.31%
-1,773,0005,275,0003,485,000-1,053,000-1,916,0003,288,0001,890,00010,496,00016,789,00014,193,00020,179,00022,879,0008,273,00016,097,00027,324,00026,646,00058,206,00055,700,000
CFO
36m
-50.97%
3,257,000-797,0001,414,0001,079,0006,984,000-1,725,000-1,351,00010,749,00019,414,00018,946,00013,452,00025,811,00020,556,0007,278,00031,936,00037,277,00073,535,00036,055,000
Dividend
May 08, 20231.8 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, and S&T brands. Its Surgical Tables segment provides C-arm tables, which are surgical tables used in ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular procedures under the imagiQ and MedStone brands. The company also offers instrument care education, repair and maintenance, and inspection services. Stille AB was founded in 1841 and is headquartered in Torshälla, Sweden.
IPO date
Aug 29, 1997
Employees
103
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT